Table 3 Developed DES with biodegradable polymers for coronary arteries [17]
From: Analysis of trends and prospects regarding stents for human blood vessels
Stent | Manufacturer | Drug (Dose) | Polymer | Polymer Thickness (μm) | Stent platform | Strut Thickness (μm) |
|---|---|---|---|---|---|---|
Axxess | Devax.Inc | Biolimus A-9 (15.6 μg/mm) | PLA | N/A | SS | 112 |
BioMatrix | Biosensors International.ltd. | Biolimus-A9 (15.6 μg/mm) | PLA | 10 | SS | 137 |
Cardiomind | CardioMind, Inc. | Sirolimus (5.2 μg/mm) | PLA + PGLA | N/A | Nitinol | 61 |
Champion | Boston Scientific Corporation | Everolimus | PLA | N/A | SS | N/A |
Corio | Cordis Corporation | Pimecrolimus | N/A | N/A | CoCr | 89 |
CoStar | Cordis Corporation | Paclitaxel | PLGA | N/A | CoCr | 89 |
Cura | OrbusNeich | Sirolimus (1.7 μg/mm2) | PLA + PLGA | 5–10 | SS | 100 |
Excel | JW Medical Systems Ltd. | Sirolimus (195–376 μg) | PLA | N/A | SS | 150 |
Infinnium | Sahajanand Medical Technologies Pvt.Ltd. | Paclitaxel | PLL + PLGA+PVP | N/A | SS | 84 |
Nevo | Cordis Corporation | Sirolimus (166 μg) | PLGA | N/A | CoCr | 99 |
Nobori | Terumo Medical corporation | Biolimus A-9 | PLA | N/A | SS | 120–149 |
Stellium | DISA Vascular (Pty) Ltd. | Paclitaxel | PLGA | N/A | CoCr | N/A |
Supralimus | Sahajanand Medical Technologies Pvt.Ltd. | Sirolimus (1.4 μg/mm2) | PLLA+PLGA+PVP | N/A | SS | 80 |
Symbio | Cordis Corporation | Pimecrolimus + Paclitaxel | PLGA | N/A | CoCr | 89 |
Synchronnium | Sahajanand Medical Technologies Pvt.Ltd. | Sirolimus + Heparin | N/A | 5–6 | SS | 60 |
Xtent | Xtent. Inc. | Biolimus A-9 | PLA | N/A | CoCr | N/A |